Product Name:Ibutamoren(MK677)
CAS No:159752-10-0
Molecular Formula:C27H36N4O5S.CH4O3S
Molecular Weight:624.776
Assay:98% min
Quality Standard:USP/ISO9001
Appearance:White Powder
Supply Ability:500-800kg/month
Storage:Store at 8ºC-20ºC, protect from moisture and light.
Product name | MK-677 |
Chemical name | Ibutamoren |
Category | SARM |
CAS | 159752-10-0 |
M.W | 624.77 |
MF | C27H36N4O5S |
Half life | 24 hours |
Storage | at 20ºC 2 years |
MK 677 benefit :
The benefits of MK-677 include muscle-building, a reduction in muscle wasting, better bone density, improved sleep, and anti-aging properties. It may also have nootropic effects and it can be beneficial in treating growth hormone deficiencies. Read on for a more in-depth look at these benefits.
For Medical:
Studies have shown that nutrobal will increase both muscle mass, and bone mineral density. Moreover, it also inhibits body fat buildup, with studies showing that those who gained lean body mass did not experience any vesceral adipose tissue growth. What's more, those subjects who were put in a caloric deficit still managed to add lean muscle mass anyway.
For Athletic:
Ibutamoren (MK-677) will cause a rise in IGF-1 and growth hormone even in a diet induced nitrogen wasting state. This means that even without making any serious effort in the kitchen or the gym it is almost impossible not to gain muscle mass and lose body fat with nutrobal. Therefore, athletes can benefit in several ways from Nutrobal:
1. Fat loss
2. Muscle gain
3. Injury healing and bone strengthening
Moreover, it will also aid in such things as endurance, mood, sleep, and general health. Hence, nutrobal Mk-677 gives the athletes all the benefits of growth hormone and IGF-1 increase without the high financial cost and side effects of the HGH.
Name | NO. | Usage |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
MK-677 | 15972-10-0 |
A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
MK2866 | 841205-47-8 |
medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
SR9009 | 1379686-30-2 |
under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
Aicar | 2627-69-2 |
acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one |